How the payer market could change in the next 5 years

Mark Reinford predicts consolidation amongst big payers and consolidation in fee schedules in the payer market in the next five years. 

Advertisement

As the coder and credentialer for Keystone Urology Specialists in Lancaster, Pa., Mr. Reinford spoke with Becker’s ASC Review on his bold predictions for payers.

Editor’s note: This interview was edited lightly for clarity.

Question: What are your predictions for the payer market in the next five years?

Mark Reinford: I see more consolidation with the big payers. I predict Aetna, Cigna, UnitedHealth and the Blue Cross Blue Shields garnering more market share as they diversify their offerings both in the standard commercial market and their “boutique” — for lack of a better word — markets. 

They will also try to corner as much through the Affordable Care Act markets as possible. I do not see much relief cost-wise for the average consumer, as the deductible/out-of-pocket amounts will rise. While I would love to see “Medicare for All,” I think we may start to see some consolidation in fee schedules in some areas moving toward single-fee schedules versus multiple-fee schedules.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 5 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.